Literature DB >> 23946315

Ataxia telangiectasia presenting as dopa-responsive cervical dystonia.

Gavin Charlesworth1, Mahavir D Mohire, Susanne A Schneider, Maria Stamelou, Nicholas W Wood, Kailash P Bhatia.   

Abstract

OBJECTIVE: To identify the cause of cervical dopa-responsive dystonia (DRD) in a Muslim Indian family inherited in an apparently autosomal recessive fashion, as previously described in this journal.
METHODS: Previous testing for mutations in the genes known to cause DRD (GCH1, TH, and SPR) had been negative. Whole exome sequencing was performed on all 3 affected individuals for whom DNA was available to identify potentially pathogenic shared variants. Genotyping data obtained for all 3 affected individuals using the OmniExpress single nucleotide polymorphism chip (Illumina, San Diego, CA) were used to perform linkage analysis, autozygosity mapping, and copy number variation analysis. Sanger sequencing was used to confirm all variants.
RESULTS: After filtering of the variants, exome sequencing revealed 2 genes harboring potentially pathogenic compound heterozygous variants (ATM and LRRC16A). Of these, the variants in ATM segregated perfectly with the cervical DRD. Both mutations detected in ATM have been shown to be pathogenic, and α-fetoprotein, a marker of ataxia telangiectasia, was increased in all affected individuals.
CONCLUSION: Biallelic mutations in ATM can cause DRD, and mutations in this gene should be considered in the differential diagnosis of unexplained DRD, particularly if the dystonia is cervical and if there is a recessive family history. ATM has previously been reported to cause isolated cervical dystonia, but never, to our knowledge, DRD. Individuals with dystonia related to ataxia telangiectasia may benefit from a trial of levodopa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23946315      PMCID: PMC3795596          DOI: 10.1212/WNL.0b013e3182a55fa2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.

Authors:  L Bonafé; B Thöny; J M Penzien; B Czarnecki; N Blau
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

2.  Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Authors:  R Saunders-Pullman; D Raymond; A J Stoessl; D Hobson; K Nakamura; T Nakamura; S Pullman; D Lefton; M S Okun; R Uitti; R Sachdev; K Stanley; M San Luciano; J Hagenah; R Gatti; L J Ozelius; S B Bressman
Journal:  Neurology       Date:  2012-02-15       Impact factor: 9.910

3.  Familial dopa-responsive cervical dystonia.

Authors:  S A Schneider; M D Mohire; I Trender-Gerhard; F Asmus; M Sweeney; M Davis; T Gasser; N W Wood; K P Bhatia
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

4.  Biochemical hallmarks of tyrosine hydroxylase deficiency.

Authors:  C Bräutigam; R A Wevers; R J Jansen; J A Smeitink; J F de Rijk-van Andel; F J Gabreëls; G F Hoffmann
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

5.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

Review 6.  Ataxia-telangiectasia, an evolving phenotype.

Authors:  Helen H Chun; Richard A Gatti
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

7.  Clinical spectrum of ataxia-telangiectasia in adulthood.

Authors:  M M M Verhagen; W F Abdo; M A A P Willemsen; F B L Hogervorst; D F C M Smeets; J A P Hiel; E R Brunt; M A van Rijn; D Majoor Krakauer; R A Oldenburg; A Broeks; J I Last; L J van't Veer; M A J Tijssen; A M I Dubois; H P H Kremer; C M R Weemaes; A M R Taylor; M van Deuren
Journal:  Neurology       Date:  2009-06-17       Impact factor: 9.910

8.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

Authors:  S N Teraoka; M Telatar; S Becker-Catania; T Liang; S Onengüt; A Tolun; L Chessa; O Sanal; E Bernatowska; R A Gatti; P Concannon
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

9.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

Authors:  Anthony Renwick; Deborah Thompson; Sheila Seal; Patrick Kelly; Tasnim Chagtai; Munaza Ahmed; Bernard North; Hiran Jayatilake; Rita Barfoot; Katarina Spanova; Lesley McGuffog; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-07-09       Impact factor: 38.330

  9 in total
  31 in total

Review 1.  Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.

Authors:  Ajith Cherian; Naveen Kumar Paramasivan; K P Divya
Journal:  Acta Neurol Belg       Date:  2021-01-16       Impact factor: 2.396

Review 2.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

3.  Novel ATM mutation in a German patient presenting as generalized dystonia without classical signs of ataxia-telangiectasia.

Authors:  Christoph Kuhm; Constanze Gallenmüller; Thilo Dörk; Moritz Menzel; Saskia Biskup; Thomas Klopstock
Journal:  J Neurol       Date:  2015-01-09       Impact factor: 4.849

4.  Dopa-Responsive Dystonia and Chorea as a Presenting Feature in Ataxia-Telangiectasia.

Authors:  Sarah Thompson; Anand Iyer; Philip Byrd; Malcolm Taylor; Stefan Spinty
Journal:  Mov Disord Clin Pract       Date:  2014-06-11

5.  Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing.

Authors:  Michael Zech; Robert Jech; Matias Wagner; Tobias Mantel; Sylvia Boesch; Michael Nocker; Angela Jochim; Riccardo Berutti; Petra Havránková; Anna Fečíková; David Kemlink; Jan Roth; Tim M Strom; Werner Poewe; Evžen Růžička; Bernhard Haslinger; Juliane Winkelmann
Journal:  Neurogenetics       Date:  2017-08-28       Impact factor: 2.660

Review 6.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

7.  Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.

Authors:  Juei-Jueng Lin; Chin-Song Lu; Chon-Haw Tsai
Journal:  J Neurol       Date:  2017-12-30       Impact factor: 4.849

Review 8.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 9.  Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome.

Authors:  Hélio A G Teive; Adriana Moro; Mariana Moscovich; Walter O Arruda; Renato P Munhoz; Salmo Raskin; Tetsuo Ashizawa
Journal:  J Neurol Sci       Date:  2015-05-29       Impact factor: 3.181

Review 10.  Treatable inherited rare movement disorders.

Authors:  H A Jinnah; Alberto Albanese; Kailash P Bhatia; Francisco Cardoso; Gustavo Da Prat; Tom J de Koning; Alberto J Espay; Victor Fung; Pedro J Garcia-Ruiz; Oscar Gershanik; Joseph Jankovic; Ryuji Kaji; Katya Kotschet; Connie Marras; Janis M Miyasaki; Francesca Morgante; Alexander Munchau; Pramod Kumar Pal; Maria C Rodriguez Oroz; Mayela Rodríguez-Violante; Ludger Schöls; Maria Stamelou; Marina Tijssen; Claudia Uribe Roca; Andres de la Cerda; Emilia M Gatto
Journal:  Mov Disord       Date:  2017-09-01       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.